Dr. Michael Komenda has more than 10 years experience in analytical development in the pharmaceutical industry. He studied chemistry at the University of Cologne, Germany, and at the Research Center Jülich, Germany, where he gained his doctorate degree in chemistry. He joined the Pharmaceutical Industry in 2003 and has held various positions in analytical development at SCHWARZ BIOSCIENCES. After the merger with UCB, he became head of analytical development at the German site and lateron head of the Transdermal Center of Expertise within UCB. Since 2012 he is head of Analytical Development at LTS in Andernach, Germany
1. Why did you decide to do a webinar with Business Review Webinars?
In addition to workshops and conferences, webinars provide an easy access platform to share information with a broader audience at minimal or even no costs. For the audience, it is easily possible to have a look into a scientific field that may be of interest, without the need of spending money for travel, accomodation and fees. The investment is just an hour of time, which hopefully turns out to be a wise investment.
2. What are you looking forward to explaining to the audience?
I want to give people insight into the analytical testing of Transdermal Delivery Systems (TDS). Patches are still a niche market and only a relatively small number of companies have hands-on experience.
3. What is the ideal outcome you would like from doing the webinar?
The ideal outcome would be that scientists and others in product development understand that a patch is a valuable alternative to just another tablet development, and that suitable analytical techniques are available to support TDS development. For people who already work in that field, it would be interesting to trigger a scientific discussion on some open questions as follow-up.
4. Where is your favorite place in the world and why?
My favorite place is Cologne, Germany. Come here and experience the city and its people, and you will know why.
5. What motivates you?
To do something meaningful and to develop a product or a process
Join Dr. Michael Komenda who will be presenting in LTS Lohmann Therapy Systems webinar ‘Analytic considerations for testing Transdermal Delivery Systems‘ on 19th November at 3PM London/10AM New York. Register here.